Metlife (MET-PA) Other financing activities (2009 - 2026)

Metlife's Other financing activities history runs 18 years deep, the most recent figure standing at -$67.0 million for Q1 2026.

• In Q1 2026, Other financing activities rose 66.33% year-over-year to -$67.0 million; the TTM figure through Mar 2026 stood at -$129.0 million (down 304.76% YoY), while the FY2025 annual figure was -$261.0 million, down 217.04% from the prior year.
• Other financing activities was -$67.0 million for Q1 2026 at Metlife, down from -$46.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $166.0 million in Q2 2024 to a low of -$199.0 million in Q1 2025.
• Historically, Other financing activities has averaged -$28.2 million across 5 years, with a median of -$32.0 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Other financing activities plunged 1600.0% in 2022, then surged 388.24% in 2024.
• A 5-year view of Other financing activities shows it stood at -$30.0 million in 2022, then slumped by 40.0% to -$42.0 million in 2023, then soared by 297.62% to $83.0 million in 2024, then tumbled by 155.42% to -$46.0 million in 2025, then plunged by 45.65% to -$67.0 million in 2026.
• The last three Other financing activities figures came in at -$67.0 million (Q1 2026), -$46.0 million (Q4 2025), and $16.0 million (Q3 2025), per Business Quant data.